Penn Medicine Provider
Pathology and Laboratory Medicine
Zubair W. Baloch, MD, PhD
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Sindh Medical College
  • Residency: Hahnemann University Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baloch is a Penn Medicine physician.

Qualifications and experience

My research

Baran J, Bojarsky M, Halada S, Ricarte-Filho JC, Isaza A, Franco AT, Surrey LF, Bhatti T, Baloch ZW, Adzick NS, Mostoufi-Moab S, Kazahaya K, Bauer A. Low-Invasive Somatic Oncogenes and Lymph Node Metastasis in Pediatric Papillary Thyroid Cancer: Implications for Prophylactic Central Neck Dissection , Eur Thyroid J: 2024


Arisi MF, Jin X, Ravish NA, Chand MT, Baloch Z. How important are the cytomorphologic subtypes of the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan system for reporting salivary gland cytology? An institutional experience 2018-2024 , Diagn Cytopathol: 2024


Williams MD, Liu Z, Rossi ED, Agarwal S, Ryška A, Ghuzlan AA, Bychkov A, Baloch Z, Chernock R, Chiosea SL, Cipriani NA, Erkilic S, Fridman M, Hang JF, Harahap AS, Jung CK, Kakudo K, Khalil M, Khanafshar E, Kumarasinghe P, Lloyd R, Nguyen TP, Ocal IT, Prasad ML, Pusztaszeri M, Rana C, Sadow P, Sajed DP, Seethala R, Tallini G, Vuong HG, Yegen G, LiVolsi VA, Nikiforov YE. Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents , J Clin Endocrinol Metab: 2024


Torous VF, Jitpasutham T, Baloch Z, Cantley RL, Kerr DA, Liu X, Maleki Z, Merkin R, Nosé V, Pantanowitz L, Resta IT, Rossi ED, Faquin WC. Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases , Cancer Cytopathol: 2024


Tondi Resta I, Rind A, Montone KT, Livolsi VA, Baloch ZW. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions , Hum Pathol: 2024


Tondi Resta I, Gubbiotti MA, Montone KT, Livolsi VA, Baloch ZW. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features , Hum Pathol: 2024


Jitpasutham T, Andrianus S, Gubbiotti M, Nosé V, Baloch ZW, Madrigal E, Faquin WC. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases , Cancer Cytopathol: 2024


Gubbiotti MA, Andrianus S, Baloch Z. THADA-IGF2BP3 fusions detected in fine-needle aspiration specimens of thyroid nodules: An institutional experience , Diagn Cytopathol, 51(6): 2023,349-355


Tondi-Resta I, Hobday SB, Gubbiotti MA, Jalaly JB, Rassekh CH, Montone KT, Baloch ZW. Carcinoma Ex Pleomorphic Adenomas: An Institutional Experience and Literature Review , Am J Clin Pathol, 159: 2023,502-515


Chiosea S, Hodak SP, Yip L, Abraham D, Baldwin C, Baloch Z, Gulec SA, Hannoush ZC, Haugen BR, Joseph L, Kargi AY, Khanafshar E, Livhits MJ, McIver B, Patel K, Patel SG, Randolph GW, Shaha AR, Sharma J, Stathatos N, van Zante A, Carty SE, Nikiforov YE, Nikiforova MN. Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management , J Clin Endocrinol Metab: 2023


View all publications